sepsis/septic shock during a seven-month period after implementation of the SS-BPA. The control group consisted of patients meeting the same criteria over a prior sevenmonth period. The primary outcome was in-hospital mortality. Secondary outcomes included hospital length of stay (LOS), time to antibiotic administration and proportion of patients that received antibiotics within the target 60 minutes. A multivariable logistic regression analysis was conducted to adjust for potential confounding variables. Results: The baseline characteristics of the study groups were similar, except for SOFA score (median score 5 vs. 4, p=0.05). Time to antibiotics was significantly reduced in the SS-BPA cohort (61.5 vs. 29 minutes, p<0.001). In addition, there was a higher proportion of patients that received antibiotics within 60 minutes (48.6 vs. 76.7%, p<0.001). On multivariable analysis, in-hospital mortality was not significantly reduced in the intervention group (OR 0.64; 95% CI, 0.26-1.57). Multivariable analysis of LOS indicated a significant reduction among patients in the SS-BPA cohort (geometric mean ratio 0.66; 95% CI, 0.53-0.82). Conclusions: Implementation of an EMR-embedded BPA for severe sepsis among ED patients improved timeliness of antibiotic administration and reduced hospital length of stay.Learning Objectives: Epidermal growth factor (EGF) is a cytoprotective peptide that has protective effects on the intestinal mucosa in sepsis. Our previous studies show that both enterocyte-specific overexpression of EGF and systemic administration of EGF to septic immunocompetent mice confer a survival advantage. Crosstalk regularly occurs between the gut epithelium and lymphocytes under homeostatic conditions, and our data show that the CD4+ cell subset is responsible for the anti-apoptotic effect of lymphocytes on the gut epithelium in sepsis. The purpose of this study was to determine if the survival benefit of EGF is CD4-dependent. Methods: Three different groups of mice were subjected to 2x25 cecal ligation and puncture (CLP). All mice received 2 days of antibiotics, and were followed for 7-day survival. Groups were as follows: (1) Rag-/-mice (which lack lymphocytes), half of which received post-CLP EGF (total dose 150ug/kg/day, divided in 2 doses) via systemic administration, half received the same volume of saline.(2) Rag-/-mice and Fabpi-EGF mice (transgenic mice with enterocyte-specific over-expression of EGF). (3) CD4-/-(mice lacking CD4 cells) and C57BL/6 mice, both groups receiving post-CLP EGF via systemic administration. Results: Systemic EGF administration worsened septic survival of Rag-/-mice (12.5% vs. 55%, p<0.01, n=18/group). There was no survival difference between Rag-/-mice and Fabpi-EGF mice (48% vs. 52%, p=0.75, n=25/group). Despite systemic EGF administration, mortality of CD4-/-mice was significantly higher than wild-type controls. All CD4-/-mice died within five days after CLP, whereas only 65% of C57BL/6 died over the course of 7 days (p<0.05, n=16-20). Conclusions: The survival advantage pro...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.